Fertig Raymond, Tosti Antonella
University of Miami, Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, Miami, FL, USA.
Intractable Rare Dis Res. 2016 Nov;5(4):314-315. doi: 10.5582/irdr.2016.01065.
Frontal fibrosing alopecia (FFA) is a rare dermatologic disease that causes scarring and hair loss and is increasing in prevalence worldwide. FFA patients typically present with hair loss in the frontal scalp region and eyebrows which may be associated with sensations of itching or burning. FFA is a clinically distinct variant of lichen planopilaris (LPP) that affects predominantly postmenopausal women, although men and premenopausal women may also be affected. Early diagnosis and prompt treatment are necessary to prevent definitive scarring and permanent hair loss. Data from retrospective studies indicate that 5-alpha-reductase inhibitors (5aRIs) are effective in stabilizing the disease. In our clinical experience, we have seen optimal results treating FFA patients with oral finasteride in conjunction with hydroxychloroquine, topical calcineurin inhibitors (tacrolimus) and excimer laser in patients with signs of active inflammation.
额部纤维性秃发(FFA)是一种罕见的皮肤病,可导致瘢痕形成和脱发,且在全球范围内患病率呈上升趋势。FFA患者通常表现为额部头皮区域和眉毛脱发,可能伴有瘙痒或烧灼感。FFA是扁平苔藓性毛囊病(LPP)的一种临床独特变体,主要影响绝经后女性,不过男性和绝经前女性也可能受到影响。早期诊断和及时治疗对于预防永久性瘢痕形成和永久性脱发至关重要。回顾性研究数据表明,5α-还原酶抑制剂(5aRIs)在稳定病情方面有效。根据我们的临床经验,对于有活动性炎症迹象的FFA患者,联合使用口服非那雄胺、羟氯喹、外用钙调神经磷酸酶抑制剂(他克莫司)和准分子激光治疗,我们已看到了最佳效果。